VICKI: A phase Ib/II, randomized, placebo-controlled, study of venetoclax plus ado-trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Lindeman, G. J.; Hamilton, E.; Krop, I.; Lim, B.; Modi, S.; Saura, C.; Desai, R.; Danner, B. J.; Fernando, T. M.; Kong, S.; Legrand, F. A.; Nasroulah, F. |
| Abstract Title: | VICKI: A phase Ib/II, randomized, placebo-controlled, study of venetoclax plus ado-trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC) |
| Meeting Title: | 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-02-01 |
| Language: | English |
| ACCESSION: | WOS:000618737700097 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS20-OT-28-03 |
| Notes: | Meeting Abstract: OT-28-03 -- This symposium was held virtually due to COVID-19 -- Source: Wos |
